Pan-Canadian Study of Mammography Screening and Mortality from Breast Cancer

Tuesday, October 14, 2014
Pan-Canadian Study of Mammography Screening and Mortality from Breast Cancer
A Pan Canadian study involving more than 2.7 million women showed a reduction in breast cancer mortality for the screened population. An analysis of 7 out of 12 Canadian screening trials which represented 85% of the population demonstrated a 40% reduction in breast cancer mortality. This study contradicts the paper which reported the 25 year results of the Canadian National Breast Screening Study which followed nearly 90,000 women and no mortality reduction was found.

Mammography Saves LivesĀ® Initiative Still Going Strong

Tuesday, October 7, 2014
During Breast Cancer Awareness Month (Oct.) and year round, the Mammography Saves Lives® (MSL) public service campaign continues to separate breast cancer fact from fiction and clear confusion over when women should be screened.

FDA Scientists Investigating How 3-D Imaging Can Transform Medical Screening Devices

Tuesday, October 7, 2014
The Washington Post reports that scientists at the Food and Drug Administration are “investigating how 3-D imaging — the technology used to create more realistic animations in video games and movies — could transform medical screening devices.” In particular, researchers “are focused on early breast cancer detection; in a process known as tomosynthesis, new screening machines take low-dose X-rays from various angles, overlaying them to produce a 3-D rendering of a patient’s breast.” The Post explains, “Traditional mammograms create a 2-D image, and cannot show cancers hidden by overlapping tissue, according to the FDA, which last week released a consumer update (10/6) on the new technology to coincide with the start of Breast Cancer Awareness month.”

Federal Study Says Physicians Need More Information About Breast Cancer Imaging Options

Friday, October 3, 2014
Congressional Quarterly reports that the Agency for Healthcare Research and Quality (AHRQ) in conjunction with the Pacific Northwest Evidence-Based Practice Center issued a report saying that American doctors need more information about the relative benefits and drawbacks of different imaging technology available to them when diagnosing and treating breast cancer. Physicians do not always understand when to use different technologies, including magnetic resonance imaging, computed tomography, positron emission tomography, PET/CT, and bone scans. CQ describes AHRQ as “a lesser known agency within the Department of Health and Human Services that funds work helping doctors choose among competing treatments and approaches to illness.”

Research: Effect of implementation of the mass breast cancer screening programme in older women in the Netherlands: population based study

Tuesday, September 16, 2014

The study assessed the incidence of early stage and advanced stage breast cancer before and after the implementation of mass screening in women aged 70-75 years in the Netherlands.

Read review from Dr. Daniel Kopans here.



Theme picker